Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Getting Out of The House: A multicentre trial to evaluate an outdoor mobility intervention for people who have had a stroke
ISRCTN ISRCTN58683841
ClinicalTrials.gov identifier
Public title Getting Out of The House: A multicentre trial to evaluate an outdoor mobility intervention for people who have had a stroke
Scientific title A multicentre randomised controlled trial of rehabilitation aimed at improving outdoor mobility for people who have had a stroke
Acronym TOMAS (Trial of Outdoor Mobility After Stroke)
Serial number at source HTA 08/14/51
Study hypothesis What is the clinical effectiveness and cost effectiveness of treating outdoor mobility limitations after stroke with a novel targeted rehabilitation therapy intervention?

More details can be found at http://www.hta.ac.uk/project/1863

As of 13/07/2009 this record has been updated to include amendments to the inclusion and exclusion criteria. At this time, the anticipated trial dates have also been updated; the initial information at the time of registration was as follows:
Initial anticipated start date: 01/03/2009
initial anticipated end date: 28/02/2012

Further modifications to this record took place on 15/09/2009, and again on 12/03/2010.
Lay summary
Ethics approval Received from the Nottingham Research Ethics Committee (REC) 1 on the 15th June 2009 (ref: 09/H0403/55)
Study design Multicentre parallel-group individually randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria Amended as of 12/03/2010:
Point 2 below has been amended to read as follows:
2. At least six weeks since stroke

Amended as of 15/09/2009:
1. Age 18 years or over
2. At least six weeks but no longer than five years since stroke
3. Wishing to get out of the house more often
4. The participant must give informed consent before completing any study-related procedure, which means any assessment or evaluation that would not have formed part of their normal care.

Amended as of 13/07/2009:
1. Aged 18 years or over, either sex
2. At least six weeks but no longer than five years since stroke
3. Wishing to get out of the house more often
4. Able to comply with the requirements of the protocol and therapy programme
5. The participant must give informed consent before completing any study-related procedure, which means any assessment or evaluation that would not have formed part of their normal care

Initial information at time of registration:
1. Both males and females, aged 18 years or over
2. At least six weeks since stroke
3. Wishing to get out of the house more often
4. Able to comply with the requirements of the protocol and therapy programme
5. The participant or legal representative must give informed consent before completing any study-related procedure, which means any assessment or evaluation that would not have formed part of their normal care
Participants - exclusion criteria Amended as of 15/09/2009:

1. Not able to comply with the requirements of the protocol and therapy programme, in the opinion of the assessor
2. Still in post-stroke intermediate care or active rehabilitation
3. Previous enrolment in this study

Amended as of 13/07/2009:
1. Significant cognitive impairment which will impede ability to complete the assessments
2. Diagnosis likely to interfere with rehabilitation or outcome assessments e.g. terminal illness
3. Still in post-stroke intermediate care or active rehabilitation
4. Previous enrolment in this study

Initial information at time of registration:
1. Significant cognitive impairment which will impede ability to complete the assessments
2. Diagnosis likely to interfere with rehabilitation or outcome assessments e.g. terminal illness
3. Previous enrolment in this study
Anticipated start date 01/08/2009
Anticipated end date 31/07/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 676
Interventions A novel rehabilitation technique (intervention) group will be compared to a usual care (control) group:

Intervention group:
Specifically designed outdoor mobility training and practice with a skilled health professional. Intervention group participants will receive up to 7 rehabilitation outdoor mobility sessions of about an hour each over 4 months. The main component of the intervention is that therapists go repeatedly with patients to try outdoor mobility, including buses, taxis, walking, voluntary drivers and mobility scooters until they feel confident to go alone or with a companion.

Control group:
Standard verbal and written information about outdoor mobility from a skilled health professional. Control Group participants will receive what is considered clinically to be routine intervention for outdoor mobility limitations. That is, verbal advice and provision of leaflets provided over one 1-hour session.
Primary outcome measure(s) Social Function domain of the health related quality of life measure SF-36v2™ Health Survey at 6 months.
Secondary outcome measure(s) The following will be assessed at 6 and 12 months:
1. Functional ability, measured by the Nottingham Extended Activities of Daily Living Scale
2. Mobility using the Rivermead Mobility Index
3. Modified 15/09/09: The number of journeys (travel diaries) - was previously: The number and duration of journeys from the travel diaries
4. Satisfaction with outdoor mobility, assessed using one yes/no question: "Do you get out of the house as much as you would like?"
5. Mood, using the General Health Questionnaire 12
6. Carer psychological distress, measured using the General Health Questionnaire 12pt
7. EuroQol EQ-5D
8. Resource use of health and social care
9. Provision of equipment
10. Participant mortality will be collected from medical records
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications
Contact name Dr  Pip  Logan
  Address B98, Community Health Sciences
Queens Medical Centre
  City/town Nottingham
  Zip/Postcode NG7 2UH
  Country United Kingdom
  Email pip.logan@nottingham.ac.uk
Sponsor University of Nottingham (UK)
  Address Research Innovation Services
  City/town Nottingham
  Zip/Postcode NG7 2NR
  Country United Kingdom
  Sponsor website: http://www.nottingham.ac.uk/
Date applied 30/01/2009
Last edited 12/03/2010
Date ISRCTN assigned 09/02/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central